Innovation is the lifeblood of a specialty company. EBITDA Margins • Focus on organic growth combined with transformative and bolt-on acquisitions • Divested commodity businesses tied to more cyclical end markets • Expanded presence in high growth areas of sustainable solutions, specialty healthcare applications, composites and more resilient end markets 5.4% 11.5% 16.1% 2006 2018 2022PF $142 $408 $585 2006 2018 2022PF 2006 figures exclude joint venture results 19 RETURNING CASH TO SHAREHOLDERS Growing Dividend 0.1 0.1 0.2 0.5 0.6 0.7 0.8 0.9 0.9 1.0 1.0 1.0 11 12 13 14 15 16 17 18 19 20 21 22 0.16 0.20 0.26 0.34 0.42 0.50 0.58 0.72 0.79 0.81 0.85 0.95 0.99 11 12 13 14 15 16 17 18 19 20 21 22 23 ~$1Bn REPURCHASED OVER LAST 11 YEARS ~$550MM PAID OVER LAST 11 YEARS Dividends Share Repurchases Cumulative Buybacks $B n $ p e r sh ar e 2022 PRO FORMA ADJUSTED EPS Earnings Growth Expanding Profitability $0.15 $1.09 $2.08 $2.67 2009 2012 2015 2018 2022PF T H IR D Q UART ER 2022 RE S U LTS $110 $119 $0.61 $0.59 Q3 2022 PERFORMANCE (TOTAL COMPANY CONT. OPS) 21 Sales Adjusted EBITDA $818 $823 + 1% Adjusted EPS + 8% - 3% (in millions) (in millions) (+ 9% excluding FX) (+ 18% excluding FX) (+ 5% excluding FX) Q3 EBITDA BRIDGE (PRO FORMA TOTAL COMPANY) 22 Price increases more than offset raw material and supply chain impacts $ millions CAI: 68Price / Mix (44)Inflation SEM: 41Price / Mix (26)Inflation 39Net Price Benefit (14)Wage and Energy Inflation 6Clariant Color Integration Synergies 14Incentives, Other Employee Costs (11)FX $137 Q3 2022   Adjusted $ 142Q3 2021 (39)Demand Q3 2022 SEGMENT PERFORMANCE 23 CAI $587 $566 Sales $93 $93 SEM Pro Forma $326 $319 Sales $70 $62 (+ 4% excluding FX) - 4% - 2% (+ 5% excluding FX) Flat (+ 7% excluding FX) - 11% (- 7% excluding FX) $500 $585 $2.60 $2.95 FULL YEAR 2022 GUIDANCE 24 Sales Adjusted EBITDA $3,375 $3,635 Adjusted EPS (in millions) (in millions) 25 SUMMARY • Executed the plans we laid out earlier this year • Completed the Dyneema acquisition and Distribution divestiture amid challenging market conditions • Paid down debt and expect to finish the year modestly levered at 3.1x net debt to 2022 pro forma adjusted EBITDA • Expect $200 million of free cash flow in 2022 • Entering an economic slowdown with a portfolio that is better positioned than ever before • Updated our EPS guidance to $2.60 from continuing operations APPENDIX Performance Additives Pigments TiO2 Dyestuffs 3%Polyethylene 12% Nylon Polypropylene Other Raw 30% Styrenic Block Copolymer ~40% hydrocarbon based (Grey shaded materials are hydrocarbon based, includes portion of “Other Raw Materials”) Non-hydrocarbon based materials 27 • From Q2 to Q3, we have seen a 7-10% sequential decline in certain hydrocarbon-based raw materials • Other raw materials such as performance additives and pigments have shown moderate inflation sequentially from Q2 to Q3 Annual Purchases RAW MATERIAL AND SUPPLY CHAIN UPDATE Based on 2021 purchases, excludes Avient Protective Materials SEGMENT DATA U.S. & Canada Latin America 2022 PRO FORMA SEGMENT, END MARKET AND GEOGRAPHY GEOGRAPHY REVENUESEGMENT FINANCIALS 21% Building and END MARKET REVENUE (1) Total company adjusted EBITDA of $585M includes corporate costs.

HC_Industry bulletin_PDI_final.indd www.polymerdiagnostics.com Industr y Bul let in Comprehensive consulting and testing expertise for medical materials and device companies Committed to Growing with the Medical Industry Since 2009, PDI has invested over $2 million to improve and extend our capabilities to serve our medical materials and device clients. Benefi ts: As a result of side-by-side R&D and laboratory work, the two companies ultimately optimized a proprietary method for bonding the polymer disc and titanium plates. Benefi ts: As a result of side-by-side R&D and laboratory work, the two companies ultimately optimized a proprietary method for bonding the polymer disc and titanium plates.

Pro Forma Financial Information The Company acquired Avient Protective Materials (“Dyneema”) on September 1, 2022 (the “Acquisition Date”) and sold the Distribution segment on November 1, 2022. ASHISH KHANDPUR PRESIDENT & CEO 4 5 PORTFOLIO TRANSFORMATION 5 46% 66% 87% 100% 0% 20% 40% 60% 80% 100% 2005 2010 2015 2020 2023 % o f A dj us te d EB IT D A Commodity JVs Distribution Performance Products & Solutions Specialty Businesses Adjusted EBITDA from Specialty Applications SUSTAINABILITY AS A GROWTH DRIVER 7 LONG-TERM REVENUE GROWTH DRIVERS Sustainable Solutions Composites, Healthcare, Asia / LATAM Overlap Other 60%+ Key Growth Drivers Total Company Revenue Growth Drivers Long-Term Growth Rate Sustainable Solutions 8–12% Composites 8–10% Healthcare 8–10% Asia / LATAM 5% Other 0–2% Avient 6% END MARKET OBSERVATIONS (% OF COMPANY SALES) ENERGY DEFENSE TELECOMMUNICATIONS HEALTHCARE 8 TRANSPORTATION INDUSTRIAL BUILDING & CONSTRUCTION 9% CONSUMER 19% PACKAGING 23% 9 REGIONAL OBSERVATIONS (% OF COMPANY SALES) 9 41% 36% Q 4 2 0 2 3 R E S U LT S Q4 2023 PERFORMANCE VS. The presentation of these measures may be different from non-GAAP financial measures used by other companies.

Each of such adjustments has not yet occurred, are out of the Company's control and/or cannot be reasonably predicted. For the same reasons, the Company is unable to address the probable significance of the unavailable information. To provide comparable financial results, the Company references “pro forma” financial metrics, which include the business results of CMB for periods prior to the Acquisition Date.

The company reported first quarter sales of $829.0 million compared to $845.7 million in the prior year quarter. The question and answer session will follow the company’s presentation and prepared remarks. For the same reasons, the Company is unable to address the probable significance of the unavailable information.

Certificate The SKZ-Cert GmbH Zertifizierungen certifies to the company PolyOne Th.

Avient Corporation’s continued dedication to equal employment opportunity may be re-emphasized and augmented in programs of affirmative action throughout the Company, if and as required by law. It is extremely important that all employees of our Company comply with this policy.

Microsoft Word - Letter Detail Bank Account.docx Avient Colorant Malaysia Sdn Bhd Formerly Known as Clariant Masterbatches (M) Sdn Bhd Company No: 199701025292 (440790-X) Shah Alam Office: Butterworth Site: No. 79 & 80, Hicom Sector B, Lot 1232, MK. 15, Jalan Teluk Gadung 27/93A, Kawasan Industri Kecil & Sederhana, 40000 Shah Alam, Simpang Ampat, Selangor Darul Ehsan, Malaysia. 14120 S.P.S. Tel: (603) 5101 2888 Fax: (603) 5191 8718 Tel: (604) 588 0668 Fax: (604) 588 0590 www.avient.com Date : 17 May 2021 Dear Valued Customer, RE : Electronics Payment Info COMPANY : Bank Account Name: Avient Colorants Malaysia Sdn Bhd Formerly known as CLARIANT MASTERBATCHES (M) SB Business Registration No.: 199701025292 (440790X ) Address : Lot 1232, MK 15, Kawasan Industri Kecil & Sederhana, Simpang Ampat, 14120 S.P.S.

MAJOR TELECOM COMPANY B A S E S T A T I O N P H A S E S H I F T E R • Required customized Dk / Df values tailored to a unique antenna design • Quick qualification of designs and short lead times were critical to support the rapid rollout of new 5G networks • Met required Dk / Df properties using two customized solutions offering Dk 3.6, Df 0.0006 and Dk 3.1, Df 0.0007 • Accelerated speed to market due to thermoplastics’ design flexibility Custom Edgetek™ Formulations KEY REQUIREMENTS WHY AVIENT?

000870.E/24.R Würzburg, 23.05.2024 Benjamin Kirchgeßner Certification Body Certificate The SKZ - Cert GmbH certifies to the company Avient Th.